EMBECTA CORP. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
EMBECTA CORP. (EMBC) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $0 for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2025-11-25
- EMBECTA CORP. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $0.00.
- EMBECTA CORP. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EMBECTA CORP. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $4.70M, a 2.17% increase from fiscal 2022.
- EMBECTA CORP. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $4.60M.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2025-09-30 | $0.00 10-K · filed 2025-11-25 |
| 2024-09-30 | $0.00 10-K · filed 2025-11-25 |
| 2023-09-30 | $4.70M 10-K · filed 2025-11-25 |
| 2022-09-30 | $4.60M 10-K · filed 2024-12-11 |
| 2021-09-30 | $0.00 10-K · filed 2023-11-29 |
| 2020-09-30 | $0.00 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |